V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Tandem Diabetes Care Executive Compensation (FY25)

TNDM · Executive and director compensation, fiscal 2023 to 2025
Data as of September 7, 2026Latest filing (8-K): May 21, 2026
226 figures on this page: 218 cited to the filing that reported them, 8 calculated from figures it prints. See the citations
Total compensation for John Sheridan, President and Chief Executive Officer, came to $6,858,503 in fiscal 2025, and Sheridan's total moved 19.6% lower from the $8,526,238 reported for fiscal 2024. The say-on-pay proposal drew 97.2% of votes cast including abstentions in favor at the meeting held May 20, 2026 for fiscal 2025. The disclosed peer group names AngioDynamics, Artivion, AtriCure, CONMED and Dexcom, among others. The fiscal 2025 disclosure covers 5 named executive officers.
Chief executive, fiscal 2025
◇
John Sheridan
Latest say-on-pay support
=
May 20, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — John Sheridan: $8,526,238 → $6,858,503 (19.6% lower)
Say-on-pay support: 97.0% → 97.2% (0.2 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Tandem Diabetes Care's chief executive and what were they paid?
Total compensation for John Sheridan, President and Chief Executive Officer, came to $6,858,503 in fiscal 2025. Sheridan's total moved 19.6% lower from the $8,526,238 reported for fiscal 2024.
What was Tandem Diabetes Care's say-on-pay result?
The say-on-pay proposal drew 97.2% of votes cast including abstentions in favor at the meeting held May 20, 2026 for fiscal 2025.
Which companies are in Tandem Diabetes Care's peer group?
The disclosed peer group names AngioDynamics, Artivion, AtriCure, CONMED and Dexcom, among others.
What is Tandem Diabetes Care's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 73:1, against median employee compensation of $94,564.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Sheridan
President and Chief Executive Officer
◇—◇—◇—◇◇
Mark Novara
Executive Vice President, Chief Commercial Officer
◇—◇—◇—◇◇
Leigh Vosseller
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇—◇—◇◇
Elizabeth Gasser
Executive Vice President, Chief Strategy and Product Officer
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Sheridan
President and Chief Executive Officer
◇—◇—◇—◇◇
Leigh Vosseller
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇—◇—◇◇
Jean-Claude Kyrillos
Executive Vice President and Chief Operating Officer
◇—◇—◇—◇◇
Susan Morrison
Executive Vice President and Chief Administrative Officer
◇—◇—◇—◇◇
Elizabeth Gasser
Executive Vice President and Chief Strategy and Product Officer
◇—◇—◇—◇◇
Mark Novara
Executive Vice President and Chief Commercial Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
John Sheridan
President and Chief Executive Officer
◇—◇—◇—◇◇
Mark Novara
Executive Vice President and Chief Commercial Officer
◇—◇—◇—◇◇
Leigh Vosseller
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇—◇—◇◇
Elizabeth Gasser
Executive Vice President and Chief Strategy and Product Officer
◇—◇—◇—◇◇
Shannon Hansen
Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Elizabeth GasserPSU◇◇◇◇◇—◇
John SheridanPSU◇◇◇◇◇—◇
Leigh VossellerPSU◇◇◇◇◇—◇
Mark NovaraPSU◇◇◇◇◇—◇
Shannon HansenPSU◇◇◇◇◇—◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Elizabeth GasserRSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
Shannon HansenRSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
John SheridanRSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
Mark NovaraRSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
Leigh VossellerPSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Sandra Beaver
◇◇————◇
Rebecca Robertson
◇◇————◇
Christopher Twomey
◇◇————◇
Kathleen McGroddy-Goetz
◇◇————◇
Rajwant Sodhi
◇◇————◇
Peyton Howell
◇◇————◇
Joao Malagueira
◇◇————◇
Myoungil Cha
◇◇————◇
John Sheridan served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • AngioDynamics ANGO
  • Artivion AORT
  • AtriCure ATRC
  • CONMED CNMD
  • Dexcom DXCM
  • Glaukos GKOS
  • Globus Medical GMED
  • Haemonetics HAE
  • ICU Medical ICUI
  • Inogen INGN
  • Inspire Medical Systems INSP
  • Insulet PODD
  • iRhythm Technologies IRTC
  • LivaNova PLC LIVN
  • Masimo MASI
  • Nevro NVRO
  • QuidelOrtho QDEL
  • STAAR Surgical STAA

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 20, 2026=◇◇◇
2024May 21, 2025=◇◇◇
2023May 22, 2024=◇◇◇
2022May 24, 2023=◇◇◇
2021May 25, 2022=◇◇◇
2020May 18, 2021=◇◇◇
2019May 27, 2020=◇◇◇
2018June 18, 2019=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Tandem Diabetes Care files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Tandem Diabetes Care disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Tandem Diabetes Care sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Enquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Tandem Diabetes Care's disclosed peer group is defensible, who names Tandem Diabetes Care back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
226 figures on this page: 218 cited to the filing that reported them, 8 calculated from figures it prints.
218 cited to the filing
8 calculated from the filing

Documents cited

  1. 0001438133-26-000070
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001438133-26-000034
    DIRECTOR COMPENSATION PROGRAM FOR 2025 · DIRECTOR COMPENSATION TABLE · LONG-TERM INCENTIVE EQUITY COMPENSATION PROGRAM · OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END · and 1 more section
  3. 0001438133-25-000112
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001438133-25-000058
    SUMMARY COMPENSATION TABLE
  5. 0001438133-24-000118
  6. 0001438133-24-000076
    Summary Compensation Table
  7. 0001438133-23-000094
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001438133-22-000106
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001438133-21-000036
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0001438133-20-000069
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0001564590-19-022812
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Tandem Diabetes Care executive compensation, FY2023–FY2025.” https://intel.velarion.ai/comp/TNDM (accessed 2026).
Short form: data: Velarion
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Tandem Diabetes Care and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Tandem Diabetes Care discloses

The companies named in TNDM's own disclosed peer group.

AngioDynamicsArtivionAtriCureCONMEDDexcomGlaukosGlobus MedicalHaemoneticsICU MedicalInogenInspire Medical SystemsInsuletiRhythm TechnologiesLivaNova PLCMasimoSTAAR Surgical

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  The Pay Desk · Methodology · Terms · Privacy